Cabaletta Bio Inc expected to post a loss of 64 cents a share - Earnings Preview

Cabaletta Bio

17/03/2025 12:46

Cabaletta Bio Inc CABA.OQ CABA.O is expected to show no change in quarterly revenue when it reports  results on March 19 (estimated) for the period ending December 31 2024

​LSEG's mean analyst estimate for Cabaletta Bio Inc is for a loss of 64 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Cabaletta Bio Inc is $24.00​, above​ its last closing price of $1.82. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Sep. 30 2024
-0.59
-0.60
-0.62
Missed
-4
Jun. 30 2024
-0.56
-0.55
-0.56
Missed
-2.2
Mar. 31 2024
-0.47
-0.48
-0.51
Missed
-7.2​
Dec. 31 2023
-0.40
-0.39
-0.46
Missed
-17.2
​​Sep. 30 2023
-0.41
-0.40
-0.37
Beat
8.3
Jun. 30 2023
-0.44
-0.44
-0.37
Beat
16.4​
Mar. 31 2023
-0.48
-0.48
-0.45
Beat
6.3
Dec. 31 2022
-0.48
-0.45
-0.52
Missed
-15.1

This summary was machine generated March 17 at 12:46 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)